OR WAIT null SECS
October 03, 2022
Ahead of this year's annual meeting, Mohammad Rafieetary, OD, FAAO, offers a look at his presentation on diabetic retinal diseases and shares why the event shouldn't be missed.
September 17, 2022
John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA, shares highlights from his Vision Expo West presentation: "Corneal diagnostics: A-Z."
September 16, 2022
John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA, discusses his presentation titled"Keratoconus 1, 2, 3: simple management," during Vision Expo West.
September 14, 2022
With the launch of dark adaptation, Heru is now the only platform on the AMD market to include contrast sensitivity and dark adaptation exams.
September 10, 2022
Azura has secured funding to support its 2-stage study evaluating the safety, tolerability, and efficacy of AZR-MD-001, its leading candidate, for patients with contact lens discomfort who show signs of meibomian gland dysfunction.
September 08, 2022
OCS-01 is a novel, high concentration, preservative free, topical formulation of dexamethasone that has the potential to be the first topical eye drop and non-invasive treatment for DME.
August 27, 2022
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her discussion titled, "Myopia management: past, present, and future," presented during this year's 115th annual SCOPA meeting.
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her presentation on amniotic membrane treatment for anterior segment disease during the South Carolina Optometric Physicians Association’s annual meeting.
August 26, 2022
Leo P. Semes, OD, FAAO, highlights his presentation on "Artificial intelligence and telemedicine," presented during the 115th annual SCOPA meeting.
Leo P. Semes, OD, FAAO, discusses his presentation on, "A new look at AMD," during the South Carolina Optometric Physicians Association's annual meeting.
Black EyeCare Perspective to host third annual IMPACT HBCU event
Online visual acuity test gains FDA clearance
Debunking common ortho-k myths
Recent study evaluates medications associated with AAC glaucoma risk
